Related Experiment Videos
Augmentation of serum bactericidal activity by paldimycin
J I Cialdella1, R G Ulrich, V P Marshall
1Research Laboratories, Upjohn Company, Kalamazoo, MI 49001.
The Journal of Antibiotics
|May 1, 1988
Summary
Paldimycin treatment below the minimum inhibitory concentration (MIC) increases Staphylococcus aureus sensitivity to serum, leading to significant bacterial killing. This effect, observed with enlarged cells and thickened walls, enhances serum-mediated clearance of S. aureus.
Area of Science:
- Microbiology
- Pharmacology
- Bacterial Pathogenesis
Background:
- Staphylococcus aureus is a significant human pathogen.
- Understanding sub-inhibitory antibiotic effects is crucial for novel therapeutic strategies.
- Paldimycin is an antibiotic with potential antimicrobial activity.
Purpose of the Study:
- To investigate the effects of sub-minimum inhibitory concentrations (sub-MIC) of paldimycin on Staphylococcus aureus.
- To determine if paldimycin alters bacterial susceptibility to host immune factors like serum.
- To elucidate the morphological and cellular changes induced by paldimycin exposure.
Main Methods:
- Exposure of Staphylococcus aureus 502A to various concentrations of paldimycin below the MIC.
- Incubation of treated bacteria in human serum to assess viability and killing.
- Evaluation of bacterial susceptibility to phagocytosis and killing by polymorphonuclear leukocytes.
- Microscopic examination (transmission electron microscopy) of paldimycin-treated bacteria.
Main Results:
- Sub-MIC paldimycin treatment significantly enhanced the susceptibility of Staphylococcus aureus to serum killing in a concentration-dependent manner.
- Maximal serum sensitivity was observed at approximately 1/10 MIC of paldimycin, resulting in 30-50% bacterial killing within 1 hour.
- Paldimycin-treated S. aureus exhibited enlarged cell size and thickened cell walls, with observed irregularities in cell division, though bacteria remained viable and replicating.
- No increased susceptibility to phagocytosis or killing by polymorphonuclear leukocytes was noted.
Conclusions:
- Sub-MIC paldimycin confers increased serum sensitivity to Staphylococcus aureus, potentially enhancing its clearance by the host immune system.
- The observed morphological changes, including cell wall thickening and division irregularities, may contribute to the altered serum susceptibility.
- Paldimycin's effects below the MIC warrant further investigation for its therapeutic potential in managing S. aureus infections.